Evidence map›Paper›PMID 20128875›Full record

ReviewPigment cell & melanoma research2010

Roles of endothelin signaling in melanocyte development and melanoma.

Amy Saldana-Caboverde, Lidia Kos

Open access · bronzeAbstract readReview
In one paragraph

Review in Pigment cell & melanoma research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 126 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Differential Expression ofAnimals : an open access journal from MDPI · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. The Impact of MutantAnimals : an open access journal from MDPI · 2025
    Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Endothelin signaling in development.Development (Cambridge, England) · 2023
    Review
  18. Article
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Amy Saldana-CaboverdeDepartment of Biological Sciences, Florida International University, Miami, FL, USA.
Lidia Kos
Florida International University · US

Funding

MBRS RESEARCH INITIATIVE FOR SCIENTIFIC ENHANCEMENTR25GM061347 · NIGMS · FLORIDA INTERNATIONAL UNIVERSITY · PI LICKLITER, ROBERT E · 2000 to 2016
$14.7M
Generation of an UV-dependent Mouse Model of MelanomaSC2CA138175 · NCI · FLORIDA INTERNATIONAL UNIVERSITY · PI KOS, LIDIA · 2008 to 2010
$319k
NCI NIH HHS CA138175-02NCI NIH HHS SC2 CA138175NIGMS NIH HHS R25 GM061347
6 · The paper itself

Abstract

Endothelin (Edn) signaling via the G-coupled, Edn receptor type B (Ednrb) is essential for the development of melanocytes from the neural crest (NC) and has been associated with melanoma progression. Edn3 plays varying roles during melanocyte development, promoting the proliferation and self-renewal of NC-derived multi- and bi-potential precursors as well as the survival, proliferation, differentiation and migration of committed melanocyte precursors. Melanocyte differentiation is achieved via the interaction of Ednrb and Kit signaling, with Ednrb being specifically required in the final differentiation step, rather than in the initial specification of melanocytic fate. Ednrb has also been implicated in the de-differentiation of mature melanocytes, a process that takes place during the malignant transformation of these cells. Ednrb was found to be upregulated in melanoma metastases and was shown to alter tumor-host interactions leading to melanoma progression. Antagonists to this receptor were shown to inhibit melanoma cell growth and increase the apoptotic rate of these cells, and to lead to disease stabilization in melanoma patients. Thus, Edn signaling inhibition may prove useful in the treatment of certain types of melanoma.

Indexed as

AnimalsEndothelinsHumansMelanocytesMelanomaSignal TransductionEndothelins

Identifiers

PMID20128875
PMCPMC2911366
OpenAlexW1529524149

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.